FDA Proposes Process Modernization to Support New Drug Development

FDA Proposes Process Modernization to Support New Drug Development

Source: 
FDA Voice
snippet: 

The staff of the FDA’s Center for Drug Evaluation and Research (CDER) always tries to utilize cutting-edge science and up-to-date process management, befitting our stature as the global “gold standard” in drug regulation. Maintaining that standard requires us to keep up with evolving technology and the latest scientific, medical and regulatory advances.